![]() Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. | ||
Founding Date | Founding Date 1993 | Founding Date 2001 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Dunedin, NZ HQ Singapore, SG |
Employees | Employees 878% decrease | Employees 114 |
Financial | ||
Revenue (est.) | Revenue (est.) $25.9m (FY, 2022) | Revenue (est.) $11.5m (FY, 2026) |
Cost of goods | Cost of goods $28.4m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit ($2.5m) (FY, 2022) | Gross profit $13m (FY, 2026) |
Net income | Net income ($32.1m) (FY, 2022) | Net income ($35.8m) (FY, 2026) |